药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brompheniramine
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Budesonide.
Brompheniramine
Belantamab mafodotin
Budesonide may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Brompheniramine
Pitavastatin
Budesonide may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Brompheniramine
Glycochenodeoxycholic Acid
Budesonide may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.
Brompheniramine
Glycyrrhizic acid
Budesonide may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.
Brompheniramine
Pilsicainide
Budesonide may decrease the excretion rate of Pilsicainide which could result in a higher serum level.
Brompheniramine
Benzbromarone
Budesonide may decrease the excretion rate of Benzbromarone which could result in a higher serum level.
Brompheniramine
Indocyanine green acid form
Budesonide may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level.
Brompheniramine
Taurocholic acid
Taurocholic acid may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Brompheniramine
Deoxycholic acid
Deoxycholic acid may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Brompheniramine
Pitolisant
The serum concentration of Budesonide can be decreased when it is combined with Pitolisant.
Brompheniramine
Mifamurtide
The therapeutic efficacy of Mifamurtide can be decreased when used in combination with Budesonide.
Brompheniramine
Dienogest
The risk or severity of edema formation can be increased when Dienogest is combined with Budesonide.
Brompheniramine
Methyltestosterone
The risk or severity of edema formation can be increased when Methyltestosterone is combined with Budesonide.
Brompheniramine
Androstenedione
The risk or severity of edema formation can be increased when Androstenedione is combined with Budesonide.
Brompheniramine
5-androstenedione
The risk or severity of edema formation can be increased when 5-androstenedione is combined with Budesonide.
Brompheniramine
Testosterone propionate
The risk or severity of edema formation can be increased when Testosterone propionate is combined with Budesonide.
Brompheniramine
Trilostane
The risk or severity of edema formation can be increased when Trilostane is combined with Budesonide.
Brompheniramine
Testosterone undecanoate
The risk or severity of edema formation can be increased when Testosterone undecanoate is combined with Budesonide.
Brompheniramine
Testosterone enanthate
The risk or severity of edema formation can be increased when Testosterone enanthate is combined with Budesonide.